Conditions: Idiopathic Parkinson's Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 20
Healthy volunteers: no

Brief summary:
This study is designed to assess safety, tolerability and pharmacokinetic data for multiple doses of PF-06669571 in subjects with idiopathic Parkinson's disease. In addition, this study will assess whether PF-06669571 is able to demonstrate superior efficacy compared with placebo in the treatment of the motor symptoms of idiopathic Parkinson's disease.

Detailed description:

Arms:
arm 1: Once daily (QD) for 7 days arm 2: QD for 7 days

Interventions: intervention 1: PF-06669571 intervention 2: Placebo
Intervention descriptions: intervention 1: 1 milligram (mg) QD for 3 days followed by 3 mg QD for 4 days intervention 2: Placebo

Protocol document: